UTHealth To Partner With Amira Learning On Next Generation Early Literacy Assessment

Amira Learning and The University of Texas Health Science Center are bringing an fully automated ORF assessment to schools across the world, using AI.

SAN FRANCISCO, CA, USA, March 26, 2019 /EINPresswire.com/ — Amira Learning, the company re-inventing learning to read with artificial intelligence (AI), announced a partnership with The University of Texas Health Science Center at Houston (UTHealth) to deliver a next generation early literacy assessment to schools across the world. The TPRI, created by faculty at UTHealth and the University of Houston and licensed by UTHealth to Amira, is recognized as one of the most reliable and valid early literacy assessments. Amira will deliver the test online as a digital application, creating the first fully automated AI Curriculum Based Measurement (CBM) solution.

Amira, an AI Reading Assistant, is the first intelligent avatar able to listen to students read aloud, assess their mastery and deliver personalized coaching. The new partnership enables Amira to administer the TPRI assessment to K-3 students, providing a fully automated and highly reliable gauge of Oral Reading Fluency (ORF).

“The combination of Amira and TPRI creates the next generation of early literacy assessment”, said Mark Angel, CEO of Amira. “Now, school districts have the best of all worlds – a test that is scored consistently, a process that doesn’t drain away instructional time using a psychometrically reliable assessment.” Because the TPRI has had proven use for two decades, Amira will now have the ability to assess ORF across the school year with norms and benchmarks built from thousands of student observations.

The TPRI test was originally created with support from the Texas Education Agency in 1999. TPRI gained a national presence and has been a widely used assessment in American schools. The assessment supports fall screening, benchmark testing in the fall/winter/spring periods, regular progress monitoring, and dyslexia screening. The assessment encompasses English and Spanish versions.

“We are pleased to be working with Amira using their new cutting-edge AI platform with the highly regarded TPRI reading assessment program”, said Dr. Bruce Butler, Vice President for Research and Technology at UTHealth. ”We look forward to the opportunity this opens for teachers in classrooms throughout the US and worldwide”.

Amira Assessment using TPRI will be available for the 2019-2020 school year. Today, teachers spend more than 40 hours every school year delivering oral reading fluency tests and even more time manually producing running records. Amira completely automates both tasks, saving teachers time and delivering consistent and comprehensive data to school districts.

Amira Assessment is offered and supported by HMH, the world’s leading learning company.

About Amira Learning

Amira Learning is re-inventing learning to read with AI. Amira is the first interactive avatar able to assess, read along with and coach developmental readers. Amira utilizes technology developed by Carnegie Mellon University and is led by the former senior technical managers at Renaissance Learning, the leader in Reading Assessment and Practice software in K-12 classrooms. For a personalized demo of Amira, email info@amiralearning.com. For more information on Amira Learning, please visit www.Amira Learning.com.

About UTHealth

Established in 1972 by The University of Texas System Board of Regents, The University of Texas Health Science Center at Houston (UTHealth) is Houston’s Health University and Texas’ resource for health care education, innovation, scientific discovery and excellence in patient care. The most comprehensive academic health center in the UT System and the U.S. Gulf Coast region, UTHealth is home to Jane and Robert Cizik School of Nursing, John P. and Kathrine G. McGovern Medical School, and schools of biomedical informatics, biomedical sciences, dentistry, and public health. UTHealth includes UTHealth Harris County Psychiatric Center, as well as the growing clinical practices UT Physicians, UT Dentists, and UT Health Services. The university’s primary teaching hospitals are Memorial Hermann-Texas Medical Center, Children’s Memorial Hermann Hospital, and Harris Health Lyndon B. Johnson Hospital. For more information, visit www.uth.edu.

Mark Angel
Amira Learning
+1 707-689-2694
email us here


Source: EIN Presswire

Author and Menopause Expert Dr. Anna Garrett to be Featured on CUTV News Radio

ASHEVILLE, NORTH CAROLINA, UNITED STATES, March 26, 2019 /EINPresswire.com/ — CUTV News today announced it will feature menopause expert Dr. Anna Garrett in an interview with Jim Masters on Thursday, March 28th at 1pm EDT.

Dr. Anna Garrett is the author of Perimenopause: The Savvy Sister's Guide to Hormone Harmony due Monday April 7th, 2019.

“This book is all about what to expect when you’re expecting menopause,” says Dr. Garrett. “I want to create a whole generation of women who know what's coming so we can eliminate all this mystery around menopause and all the misery that goes along with it.”

Dr. Garrett combines her experience as a pharmacist and certified coach to help women navigate perimenopause.

“We have generally thought of menopause as all about hot flashes, because that's what is portrayed in media,” says Dr. Garrett, “but there’s also anxiety, weight gain, insomnia, dry eyes, short-term memory loss, muscle aches, bladder incontinence, even pain during sex.”

“It’s frustrating for me to watch women suffer needlessly because there are options to make perimenopause and menopause more manageable.”

The women Dr. Garrett works with tend to want to avoid hormone replacement, so the focus is primarily on lifestyle and supplementation. Still, that doesn’t mean hormones should not be a consideration. In fact, they very well could be the answer.

According to a recent survey, only 20 percent of OBGYN residency programs offer hormone education. Doctors simply don't receive adequate training in hormones in medical school or in residency, but they’re supposed to be the experts. In addition, many physicians are still operating on data from a Women's Health Initiative study in 2002, which claimed estrogen replacement therapy could lead to an increased risk of cancer, effectively eliminating hormone replacement as an option and shutting the door on the science of hormones.

While it’s true that hormone replacement is a little bit chemistry and a little bit alchemy—there's as much art to it as science—hormone testing can help determine any imbalances.

“We don't take a shotgun approach to hormones,” says Dr. Garrett. “When they work with me, the first step is to do a very detailed health history and get an idea of what their goals are, what they want to accomplish. We create a customized plan of recommendations for lifestyle and supplements and, if necessary, bio-identical hormone replacement. Some women take the plan and go and implement it themselves. For others those who need help with implementation, we develop an ongoing coaching relationship to accomplish that.”

Listen to the show on BlogTalkRadio

If you have a question for our guest, call (347) 996-3389

For more information on Dr. Anna Garrett, visit www.drannagarrett.com

Perimenopause: The Savvy Sister's Guide to Hormone Harmony is available for preorder on Amazon

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Is Dye Sensitized Solar Cell the Next Big Thing in New Solar Energy?

Award Winning Three Roll Mills

Award Winning Three Roll Mills

Award Winning Belt Furnace

Award Winning Belt Furnace

Buy American Act

It is the only photovoltaic technology that mimics photosynthesis to produce electricity.

SAN DIEGO, CA, UNITED STATES, March 26, 2019 /EINPresswire.com/ — Per Wikipedia, A dye-sensitized solar cell (DSSC, DSC, DYS or Grätzel cell) is a low-cost solar cell belonging to the group of thin film solar cells. It is based on a semiconductor formed between a photo-sensitized anode and an electrolyte, a photoelectrochemical system. The modern version of a dye solar cell, also known as the Grätzel cell, was originally co-invented in 1988 by Brian O'Regan and Michael Grätzel at UC Berkeley and this work was later developed by the aforementioned scientists at the École Polytechnique Fédérale de Lausanne until the publication of the first high efficiency DSSC in 1991. Michael Grätzel has been awarded the 2010 Millennium Technology Prize for this invention.

The DSSC has a number of attractive features; it is simple to make using conventional roll-printing techniques, is semi-flexible and semi-transparent which offers a variety of uses not applicable to glass-based systems, and most of the materials used are low-cost. In practice it has proven difficult to eliminate a number of expensive materials, notably platinum and ruthenium, and the liquid electrolyte presents a serious challenge to making a cell suitable for use in all weather. Although its conversion efficiency is less than the best thin-film cells, in theory its price/performance ratio should be good enough to allow them to compete with fossil fuel electrical generation by achieving grid parity. Commercial applications, which were held up due to chemical stability problems, are forecast in the European Union Photovoltaic Roadmap to significantly contribute to renewable electricity generation by 2020.

Nonetheless, due to technical constraints, the maximum efficiency is only half the efficiency of crystalline silicon-based solar cells. In an effort to replace the solar technologies we currently use, improving the efficiency of DSSC technology is critical for widespread adoption. The process parameters have a significant impact on determining the efficiency of the solar cell, as well as, the materials being applied. We will attempt to summarize the influence of material selection, the sintering process, and belt furnace parameters on the efficiency of dye-sensitized solar cells.

Please continue to read this article here https://beltfurnaces.com/white-paper-efficiency-of-dssc.html.

This information is brought to you by Torrey Hills Technologies, LLC, San Diego, CA 92121. We export heat sinks, belt furnaces and three roll mills to 60+ countries.

Ken Kuang
Torrey Hills Tech, LLC
+1 8585586666
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Nanobots Market Insights 2019, Top Competitors, Share Growth and Future Forecast to 2025

PUNE, MAHARASHTRA, INDIA, March 26, 2019 /EINPresswire.com/ — Robotics is a technology used for production of robots and nanorobots. Nanobots are used in various fields for different tasks to be performed thus reducing human errors.

The global Nanobots market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Nanobots volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanobots market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/3852479-global-nanobots-market-research-report-2019

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Xidex Corp

Zymergen Inc

Synthace Limited

Ginkgo Bioworks

Advanced Diamond Technologies

Advanced Nano Products Co Limited

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Microbivore Nanorobots

Respirocyte Nanorobots

Clottocyte Nanorobots

Cellular Repair Nanorobots

Segment by Application

Nano Medicine

Biomedical

Mechanical

Other applications

View Detailed Report at https://www.wiseguyreports.com/reports/3852479-global-nanobots-market-research-report-2019

Table of Contents

Executive Summary

1 Nanobots Market Overview

1.1 Product Overview and Scope of Nanobots

1.2 Nanobots Segment by Type

1.2.1 Global Nanobots Production Growth Rate Comparison by Type (2014-2025)

1.2.2 Microbivore Nanorobots

1.2.3 Respirocyte Nanorobots

1.2.4 Clottocyte Nanorobots

1.2.5 Cellular Repair Nanorobots

1.3 Nanobots Segment by Application

1.3.1 Nanobots Consumption Comparison by Application (2014-2025)

1.3.2 Nano Medicine

1.3.3 Biomedical

1.3.4 Mechanical

1.3.5 Other applications

1.4 Global Nanobots Market by Region

1.4.1 Global Nanobots Market Size Region

1.4.2 North America Status and Prospect (2014-2025)

1.4.3 Europe Status and Prospect (2014-2025)

1.4.4 China Status and Prospect (2014-2025)

1.4.5 Japan Status and Prospect (2014-2025)

1.5 Global Nanobots Market Size

1.5.1 Global Nanobots Revenue (2014-2025)

1.5.2 Global Nanobots Production (2014-2025)

2 Global Nanobots Market Competition by Manufacturers

2.1 Global Nanobots Production Market Share by Manufacturers (2014-2019)

2.2 Global Nanobots Revenue Share by Manufacturers (2014-2019)

2.3 Global Nanobots Average Price by Manufacturers (2014-2019)

2.4 Manufacturers Nanobots Production Sites, Area Served, Product Types

2.5 Nanobots Market Competitive Situation and Trends

2.5.1 Nanobots Market Concentration Rate

2.5.2 Nanobots Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

………………………………

………………………………

7 Company Profiles and Key Figures in Nanobots Business

7.1 Xidex Corp

7.1.1 Xidex Corp Nanobots Production Sites and Area Served

7.1.2 Nanobots Product Introduction, Application and Specification

7.1.3 Xidex Corp Nanobots Production, Revenue, Price and Gross Margin (2014-2019)

7.1.4 Main Business and Markets Served

7.2 Zymergen Inc

7.2.1 Zymergen Inc Nanobots Production Sites and Area Served

7.2.2 Nanobots Product Introduction, Application and Specification

7.2.3 Zymergen Inc Nanobots Production, Revenue, Price and Gross Margin (2014-2019)

7.2.4 Main Business and Markets Served

7.3 Synthace Limited

7.3.1 Synthace Limited Nanobots Production Sites and Area Served

7.3.2 Nanobots Product Introduction, Application and Specification

7.3.3 Synthace Limited Nanobots Production, Revenue, Price and Gross Margin (2014-2019)

7.3.4 Main Business and Markets Served

7.4 Ginkgo Bioworks

7.4.1 Ginkgo Bioworks Nanobots Production Sites and Area Served

7.4.2 Nanobots Product Introduction, Application and Specification

7.4.3 Ginkgo Bioworks Nanobots Production, Revenue, Price and Gross Margin (2014-2019)

7.4.4 Main Business and Markets Served

7.5 Advanced Diamond Technologies

7.5.1 Advanced Diamond Technologies Nanobots Production Sites and Area Served

7.5.2 Nanobots Product Introduction, Application and Specification

7.5.3 Advanced Diamond Technologies Nanobots Production, Revenue, Price and Gross Margin (2014-2019)

7.5.4 Main Business and Markets Served

7.6 Advanced Nano Products Co Limited

7.6.1 Advanced Nano Products Co Limited Nanobots Production Sites and Area Served

7.6.2 Nanobots Product Introduction, Application and Specification

7.6.3 Advanced Nano Products Co Limited Nanobots Production, Revenue, Price and Gross Margin (2014-2019)

7.6.4 Main Business and Markets Served

8 Nanobots Manufacturing Cost Analysis

8.1 Nanobots Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Nanobots

8.4 Nanobots Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.2 Nanobots Distributors List

9.3 Nanobots Customers

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities

10.3 Market Drivers

10.4 Challenges

10.5 Influence Factors

……………………………………………….

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:

NORAH TRENT

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Transient Ischemic Attack Market 2019 Global Technology, Development, Trends and Forecasts to 2023

New Study On “2019-2023 Transient Ischemic Attack Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast”

PUNE , MAHARASHTRA, INDIA, March 26, 2019 /EINPresswire.com/ — Global Transient Ischemic Attack Industry

New Study On “2019-2023 Transient Ischemic Attack Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Transient ischemic attacks or mini-strokes are often caused by the loss of blood flow in the retina, spinal cord or brain. The effect of the stroke doesn’t last for long and even doesn’t cause any permanent damage to the person; however, the chances of occurrence of major stroke becomes very likely for the person once contracted with a mini-stroke. The excessive consumption of alcohol and an increased number of smokers is one of the major factors driving the market growth across the globe. Moreover, the rapid increase in cardiac and neurological disorders are owing to the high cholesterol level and high blood pressure are some other factors fueling the market growth. The high treatment cost and lack of awareness about diagnosis and treatment of the diseases, majorly in emerging and underdeveloped economies significantly restrain the growth of the market. The increased government spending on healthcare facilities and technological advancement in diagnostic tools and treatment technologies is anticipated to mark growth opportunities for the market in the near future. 

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3739580-global-transient-ischemic-attack-market-research-and-forecast-2018-2023

Geographically, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a dominant position in the global transient ischemic attack market due to the presence of a large number of patients with neurological disorders and cardiac diseases. Moreover, the availability of advanced healthcare facilities further augments the market growth in the region. Asia-Pacific is projected to exhibit the fastest growth rate in the global transient ischemic attack market during the forecast period. This is mainly owing to the adoption of a sedentary lifestyle and increasing consumption of tobacco and alcohol in the region. Europe holds a second dominant position in the global transient ischemic attack market, owing to the high focus of government organizations in the development of healthcare infrastructure and increasing awareness about treatment and diagnosis of minor stroke. 
The company engaged in transient ischemic attack market are continuously developing various types of medications and diagnostic devices for the treatment of the disease. Some of the key players operating in the transient ischemic attack market are Abbott Laboratories, Bayer AG, Boston Scientific Corp., Cardinal Health, Inc., electroCore, Inc., GE Healthcare, LivaNova PLC, Medtronic, PLC, Merck KGaA, Novartis AG, Novo Nordisk A/S, and Sanofi SA, among others. The companies are working on developing innovative valvular heart diseases treatment system through research and innovation, expansion, M&A, product launch of the innovative product in their core competency in order to expand individual market share. 
Research methodology 
The market study of global transient ischemic attack market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports. 
Secondary sources include 
• Financial reports of companies involved in the market 
• Authentic Public Databases 
• Whitepapers such as research papers and news blogs 
• Company websites and their product catalog. 
The report is intended for researchers in the healthcare sector, emerging companies, and investment companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in the market and will serve as a source for 360-degree analysis of the market. 
Market segmentation 
Global transient ischemic attack market is segmented on the basis of various regions and below mentioned segments: 
1. Global Transient Ischemic Attack Market Research and Analysis by Diagnosis 
2. Global Transient Ischemic Attack Market Research and Analysis by Treatment 
3. Global Transient Ischemic Attack Market Research and Analysis by End-Users 
4. Global Transient Ischemic Attack Market Research and Analysis by Region 
The report covers 
• Comprehensive research methodology of global transient ischemic attack market. 
• This report also includes a detailed and extensive market overview with key analyst insights. 
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
• Analysis of regional regulations and other government policies impacting the global transient ischemic attack market. 
• Insights about market determinants which are stimulating the global transient ischemic attack market. 
• Detailed and extensive market segments with regional distribution of forecasted revenues. 
• Extensive profiles and recent developments of market players. 
Companies Mentioned 
1. Abbott Laboratories 
2. Bayer AG 
3. Boston Scientific Corp. 
4. Cardinal Health, Inc. 
5. Cigna Corp. 
6. DAIICHI SANKYO CO., LTD. 
7. electroCore, Inc. 
8. Eli Lilly and CO. 
9. General Electric Co. 
10. LivaNova PLC 
11. Medtronic, PLC 
12. Merck KGaA 
13. Novartis AG 
14. Novo Nordisk A/S 
15. Pfizer Inc. 
16. Sanofi SA 
17. Siemens Healthcare Pvt. Ltd. 
18. Stryker Corp. 
19. TERUMO CORP. 
20. Zocere, Inc.

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3739580-global-transient-ischemic-attack-market-research-and-forecast-2018-2023

Some Major Points from Table of content:

REPORT SUMMARY 
1.1. Research Methods and Tools 
1.2. Market Breakdown 
      1.2.1. By Segments 
      1.2.2. By Geography 
      1.2.3. By Stakeholders 
2. MARKET OVERVIEW AND INSIGHTS 
    2.1. Definition 
    2.2. Analyst Insights & Current Market Trends 
      2.2.1. Key Findings 
      2.2.2. Recommendation 
      2.2.3. Conclusion 
    2.3. Rules & Regulation 
3. MARKET DETERMINANT 
    3.1. Motivators 

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Transcatheter Aortic Valve Replacement Market 2019 Industry Analysis, Segment & Forecast Up to 2023

New Study On “2019-2023 Transcatheter Aortic Valve Replacement Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast”

PUNE , MAHARASHTRA, INDIA, March 26, 2019 /EINPresswire.com/ — Global Transcatheter Aortic Valve Replacement Industry

New Study On “2019-2023 Transcatheter Aortic Valve Replacement Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Transcatheter aortic valve replacement (TAVR) is the implantation of the aortic valve in the heart through the blood vessels unlike in case of valve replacement as done in open heart surgery. Rising valvular diseases and increasing prevalence of aortic stenosis has been the major factor driving the market growth. According to the American Heart Association, in the US, more than 80,000 aortic valve replacement procedures are performed every year which shows the demand for heart valve implantation. Additionally, the TAVR has been approved by the regulatory bodies and are available for patients receiving Medicaid and Medicare facilities. Such reimbursement policies further motivate the growth of the global TAVR market. 

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3739579-global-transcatheter-aortic-valve-replacement-market-forecast-2018-2023

However, the government stringent regulations for product approval have been hindering the market growth. According to Food and Drug Administration (FDA), as 77% and 80% of the total cost in the commercialization of class II and class III medical device is usually expended at FDA-linked approval stages, which in turn, hinders the market growth. Furthermore, the high cost of replacement procedures and lack of skilled technicians are hindering the market growth. Moreover, the ongoing improvements in the healthcare expenditure are expected to support the TAVR market, drive the market growth in emerging economies across the globe. 
The TAVR market is further analyzed on a geographical standpoint, including North America, Asia-Pacific, Europe, and Rest of the World. North America has been predicted to dominate the global TAVR market due to high awareness among population towards these procedures and favorable reimbursement policies in the region. Additionally, Asia-Pacific is anticipated to witness the fastest growth rate in the global TAVR market during the fastest period due to rising geriatric population and increasing incidence and prevalence rate of heart diseases. 
The key players operating in the global TAVR market include Medtronic PLC, Cardiosolutions, Inc., Abbott Laboratories, Boston Scientific Corp., and JenaValve Technology, among others. These players adopt various strategies such as partnership, R&D, merger & acquisition, product launch, joint ventures and so forth. For instance, Edwards Lifesciences Corporation received MHLW approval for its SAPIEN 3 transcatheter heart valve for the Japanese market in March 2016. 
Research methodology 
The market study of TAVR market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to get first-hand information. Primary research brings authenticity to our reports. 
Secondary sources include 
• Financial reports of companies involved in the market 
• Authentic Public Databases such as American Heart Association, and others 
• Whitepapers, research-papers and news blogs 
• Company websites and their product catalog 
The report is intended for pharmaceutical and biotechnology companies, healthcare providers, investment companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions. 
Market segmentation 
Global TAVR market is segmented on the basis of regional outlook and following segments: 
1. Global Transcatheter Aortic Valve Replacement Market Research and Analysis by Approach 
2. Global Transcatheter Aortic Valve Replacement Market Research and Analysis by Region 
The report covers 
• Comprehensive research methodology of the global transcatheter aortic valve replacement market. 
• This report also includes a detailed and extensive market overview with key analyst insights. 
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
• Analysis of regional regulations and other government policies impacting the global transcatheter aortic valve replacement market. 
• Insights about market determinants which are stimulating the global transcatheter aortic valve replacement market. 
• Detailed and extensive market segments with regional distribution of forecasted revenues. 
• Extensive profiles and recent developments of market players. 
Companies Mentioned 
1. 4C Medical Technologies 
2. Abbott Laboratories 
3. Aortech International PLC 
4. Boston Scientific Corp. 
5. Braile Biomédica 
6. Cardiosolutions, Inc. 
7. Colibri Heart Valve LLC 
8. CryoLife, Inc. 
9. Edwards Lifesciences Corp. 
10. HighLife 
11. HLT, Inc. 
12. JC Medical, Inc. 
13. JenaValve Technology, Inc. 
14. Lepu Medical Technology (Beijing) Co., Ltd 
15. LivaNova PLC 
16. Medtronic, PLC 
17. Meril Life Sciences Pvt. Ltd. 
18. Micro Interventional Devices, Inc. 
19. Neovasc Inc. 
20. TTK Healthcare Ltd.

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3739579-global-transcatheter-aortic-valve-replacement-market-forecast-2018-2023

Some Major Points from Table of content:

REPORT SUMMARY 
1.1. Research Methods and Tools 
1.2. Market Breakdown 
      1.2.1. By Segments 
      1.2.2. By Geography 
      1.2.3. By Stakeholders 
      1.2.4. Exceptions 
2. Market Overview and Insights 
    2.1. Definition 
    2.2. Analyst Insights & Current Market Trends 
      2.2.1. Key Findings 
      2.2.2. Recommendation 
      2.2.3. Conclusion 
    2.3. Rules & Regulations 
 Continued….

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Breast Prosthesis Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Breast Prosthesis Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MARKETERSMEDIA, INDIA, March 26, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Breast Prosthesis Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Breast Prosthesis Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Breast Prosthesis Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Breast Prosthesis market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Allergan Inc.?Actavis?
Arion Laboratories
CEREPLAS
Establishment Labs
GC Aesthetics
GROUPE SEBBIN
Guangzhou Wanhe Plastic Materials
Hans Biomed
Ideal Implant
Mentor Worldwide LLC (Johnson & Johnson)
POLYTECH Health & Aesthetics
Sientra Inc
Silimed

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3439116-2015-2023-world-breast-prosthesis-market-research-report

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Silicone Gel
Saline Solution

By End-User / Application
Hospital
Beauty Clinic
Other

At any Query @ https://www.wiseguyreports.com/enquiry/3439116-2015-2023-world-breast-prosthesis-market-research-report

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

….

12 Key Manufacturers
12.1 Allergan Inc.?Actavis?
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Arion Laboratories
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 CEREPLAS
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Establishment Labs
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 GC Aesthetics
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 GROUPE SEBBIN
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Guangzhou Wanhe Plastic Materials
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Hans Biomed
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Ideal Implant
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Mentor Worldwide LLC (Johnson & Johnson)
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 POLYTECH Health & Aesthetics
12.12 Sientra Inc
12.13 Silimed

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3439116

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1-646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Thrombus Precursor Protein Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Thrombus Precursor Protein Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MARKETERSMEDIA, INDIA, March 26, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Thrombus Precursor Protein Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Thrombus Precursor Protein Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Thrombus Precursor Protein Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Thrombus Precursor Protein market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Randox Laboratories
Beckman Coulter
Response Biomedical
LSI Medience Corporation
F. Hoffmann-La Roche
Biomerieux SA
Singulex
BG Medicine
Alere

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3439103-2015-2023-world-thrombus-precursor-protein-market-research

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Sheep Source
Chicken Source
Monkey Source
Dog Source
Rabbit Source
Mouse Source
Human Source
Others Source

By End-User / Application
Clinics
Research Institutions
Hospitals
Diagnostic Centers

At any Query @ https://www.wiseguyreports.com/enquiry/3439103-2015-2023-world-thrombus-precursor-protein-market-research

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

….

12 Key Manufacturers
12.1 Randox Laboratories
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Beckman Coulter
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Response Biomedical
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 LSI Medience Corporation
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 F. Hoffmann-La Roche
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Biomerieux SA
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Singulex
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 BG Medicine
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Alere
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3439103

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Placenta Extract Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Placenta Extract Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MARKETERSMEDIA, INDIA, March 26, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Placenta Extract Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Placenta Extract Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Placenta Extract Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Placenta Extract market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
BioContinental
Galtec Australia
Anzchem Pty Ltd
BIOFAC A/S
XABC Biotech Co., Ltd
Lanzhou Mingde
Shaanxi Sciphar
Xian Shandao Co
Suzhou Tianlong Co Ltd
Neimenggu Xinhong Biotech

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3439102-2015-2023-world-placenta-extract-market-research-report

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Sheep Placenta Extract Powders
Sheep Placenta Extract Fluids

By End-User / Application
Dietary
Pharmaceutical
Cosmetics

At any Query @ https://www.wiseguyreports.com/enquiry/3439102-2015-2023-world-placenta-extract-market-research-report

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

….

12 Key Manufacturers
12.1 BioContinental
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Galtec Australia
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Anzchem Pty Ltd
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 BIOFAC A/S
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 XABC Biotech Co., Ltd
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Lanzhou Mingde
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Shaanxi Sciphar
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Xian Shandao Co
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Suzhou Tianlong Co Ltd
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Neimenggu Xinhong Biotech
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3439102

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Drugs for Solid Tumors Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

WiseGuyReports.com adds “Drugs for Solid Tumors Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”

PUNE, MARKETERSMEDIA, INDIA, March 26, 2019 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Drugs for Solid Tumors Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Drugs for Solid Tumors Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Drugs for Solid Tumors Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Drugs for Solid Tumors market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
Eli Lilly
GSK
Merck
Sanofi
AbbVie
AstraZeneca
Bayer
Biogen
Boehringer Ingelheim
Boston Biomedical
Daiichi Sankyo

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3439154-2015-2023-world-drugs-for-solid-tumors-market

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Small Molecules
Biologics

By End-User / Application
Hospitals
Clinics
Academic and Research Institutes

At any Query @ https://www.wiseguyreports.com/enquiry/3439154-2015-2023-world-drugs-for-solid-tumors-market

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

….

12 Key Manufacturers
12.1 Hoffmann-La Roche
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Novartis
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Celgene
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Johnson & Johnson
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Pfizer
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 BMS
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Eli Lilly
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 GSK
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Merck
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Sanofi
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 AbbVie
12.12 AstraZeneca
12.13 Bayer
12.14 Biogen
12.15 Boehringer Ingelheim
12.16 Boston Biomedical
12.17 Daiichi Sankyo

Buy NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3439154

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire